#TerrAscend

[growersnsmokers]

Wow, this story that broke a couple days ago with a guy who found a pencil in a pre-rolled joint in BC. I have a hard time believing a pencil can just mistakenly fall in a joint. But who knows? The company has just banned pencils and wooden items in the production area. #growersnsmokers #breakingnews #havenstreet #terrascend #pencilpushers #banpencils #prerolledjoints #britishcolumbia #dispensary https://www.instagram.com/p/B3LcKRpgx7n/?igshid=ft3h59a5ob6p

[cannachiefsmedia-blog]

#20 Dr. Michael Nashat, Pharm. D.

Corporate Bio

TerrAscend’s co-founder and CEO, Dr. Michael Nashat, Pharm. D., has over 12 years of experience in patient care, quality assurance, medical and regulatory affairs and R&D. Prior to co-founding TerrAscend, Dr. Nashat cofounded and was the Executive Director of OnPharm Independent Pharmacy Group, the largest independent non banner group in Canada with over 500 pharmacies. Dr. Nashat is a former board member of the Canadian Association of Chain Drug Stores, Ontario College of Pharmacists and the Canadian Foundation for Pharmacy. Dr. Nashat is a former member of the Ontario Ministry of Health and Long Term Care’s Pharmacy Council and the former Vice Chair of the Ontario Pharmacists Association’s Owners Advisory Council. Dr Nashat received his Doctor of Pharmacy Magna Cum Laude from the Albany College of Pharmacy and Health Sciences and completed his Post-Doctoral Fellowship in Neuroscience Medical Strategy at Rutgers University and Bristol-Myers Squibb.

Social Media Links:      Twitter      Linked In      Instagram

How did you get involved with the Cannabis Industry?

What is your biggest accomplishment to date in the Cannabis Industry?

What are your future goals?

Who/what Inspires you?

Do you use Cannabis products? If yes, what are your favorite Cannabis products/brands?

[grizzlemedia-blog]

Creso Pharma Enjoys Shares Boost After TerrAscend Deal

Shares in Australian cannabis producer Creso Pharma (ASX: CHP) jumped 9% after it announced a three-year deal to supply the Canadian market. Creso Pharma is based in Bangaroo, New South Wales, while it also has an office in Switzerland and it is building a 24,000 sq. ft. production facility in Nova Scotia. It is ramping up its Canadian operations by tying up a three-year supply deal with TerrAscend Canada. TerrAscend is a producer and also a retailer via an ecommerce platform called Solace Health, which aims to provide patients with a unique one-stop-shop for all of their medical cannabis and accessory needs. Creso Pharma will supply it with a minimum of 100 kilos of cannabis flower per month over the next three years. Creso chief operating officer John Griese said that his firm is “quietly building a diverse global enterprise”. It follows news of an export deal that it tied up with a Sri Lankan distributor to supply the Asian nation with its flagship product, cannAFFORD 50. It also expanded its footprint in New Zealand by signing a letter of intent with Kiwi firm Medleaf to distribute its full product range. The duo will team up to explore local research, cultivation, extraction, and future product development. Medleaf called Creso one of the cannabis industry’s “innovation leaders”. But it is by no means confining its efforts to humans. Creso also has grand plans to become the market leader in the pet CBD market. It claims that there has been a huge rise in CBD products as over-the-counter medicine for pets, following reports from vets and pet owners suggesting that CBD promotes wellbeing, balances behaviour, and reduces tiredness and fatigue. Creso calls it a natural way to keep pets well adjusted and ensure comfort in old age. Its product, anibidiol(R), is produced in Switzerland, and it is already generating revenue in Europe, so it believes it can crack North America and other markets too. “Few cannabis companies are currently commercial in countries across Europe and even less have established proprietary branded products such as Creso’s CBD-based Nutraceuticals cannaQIX and anibidiol in human and animal health,” said Griese. Shares in the firm rose from AU$0.52 to AU$0.57 after the TerrAscend announcement was made, before settling back at AU$0.54. Read the full article

[infovisualinvesting]

​​TerrAscend improved net sales by 1,149% in 2019

[capital10x]

TerrAscend Secures Extracts and Edibles License

TerrAscend Corp. (CSE: TER.CN) has secured a license amendment from Health Canada that allows it to sell cannabis extracts, topicals, and edibles. #marijuanastocks #potstocks $TER $TER.CN Read the full article

[onpoli]

When doctors at the Solace Health Network of cannabis clinics prescribe their patients medical marijuana, one government-licensed producer of the drug might come quickly to mind.

The clinics’ parent company, after all, is Terrascend, which also owns a cannabis grower and seller.

A direct ownership link between doctor-staffed clinics and the manufacturer of their main treatment tool would be unheard of if it involved a pharmaceutical firm. But in the fast-evolving cannabis industry, Terrascend’s arrangement is far from unique — and quite legal.

The National Post has found close to a dozen companies across the country have combined pot-producing operations and marijuana-treatment clinics under the same corporate umbrella, in what seems to be a growing trend.

Some insist they isolate the two functions from each other, but others are frank about the benefits of vertical integration. The Leaf Wise clinics in Alberta, for instance, will provide “a direct channel to Invictus-owned licensed producers,” said parent-company Invictus MD Strategies in a recent news release.

“If you have clinics, then you have patients, right? And if you have patients, you can capture a portion of that,” said Chris Churchill-Smith, CEO of Canada House Wellness Group, which owns both a producer and clinics.

The trend has alarmed some health-policy experts and regulators, who warn it blurs the lines between health professionals who are supposed to be independent of commercial interests and businesses that sell the therapies they prescribe.

[gadgetsforusesblog]

Top Cannabis Stocks for May 2023

Top cannabis stocks in May include SNDL Inc., TerrAscend Corp. and Curaleaf Holdings Inc., which together lead revenue growth, even as a crowded field of competitors and a thriving illicit market hinder sales. The ETFMG Alternative Harvest ETF (MJ), a measure of the performance of cannabis stocks, is down 53% over the past year, and even the best-performing cannabis stocks are down 28% over the…

[grizzlemedia-blog]

TerrAscend Withdraws 2019 Guidance, Announces Leadership Changes

The original projection of $141 million has now been withdrawn by TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) in the wake of poor Canadian performance. #marijuanastocks #potstocks $TER $TRSSF Read the full article

[capsfromtheoc]

When will marijuana be available in new jersey

When Will Sporting Cannabis Be Free in NJ?

New Jersey administrators had at first intentionally avoided cutoff times with regard to cannabis regulation. They were worried, to a limited extent, that a race to permit legitimate deals would prompt inventory deficiencies and long queues, Goldstein said. In spite of the absence of cutoff times, Goldstein as well as authorities with the state's CRC communicated hopefulness following the April 11 endorsements about "first day of the season" for sporting weed.

Supply issues make the most ridiculously troubling issue for imminent purchasers in the months to come. Additionally, disappointments for mother-and-pop retail shops could mount on the off chance that licences for more modest pot organisations are not given for a little while, Goldstein and DiPisa said.

Where Could I at any point Purchase Weed Legitimately in NJ?

There are as of now just clinical maryjane dispensaries working in New Jersey. Those are controlled by eight public organisations, which consolidate to have 23 areas all through the state. Here is a guide of the areas.

Seven of those organisations got the last endorsements for sporting licences and will be quick to venture into that domain soon. A lot more imminent sporting retailers are likewise attempting to open in New Jersey.

As a matter of fact, the CRC has given 102 restrictive endorsements, which incorporate many little new companies. In any case, DiPisa said huge obstacles stay for fire up retailers, including getting zero-and low-interest credits and acquiring neighbourhood grants from regions to open.

Contingent endorsements are not equivalent to the seven endorsements passed out April 11 by the CRC, and are only an underlying move toward the administrative interaction toward a state permit. DiPisa said a method for working on the cycle for many more modest imminent retailers is to let loose those favourable credits during the restrictive endorsement stage. That isn't presently the situation, he said.

Why Are Large Weed Organizations Like Curaleaf and Climb Getting First Dibs on Sporting Pot in NJ?

One piece of the 2021 regulation permitting sporting pot use specified that the current clinical cannabis dispensaries would get the principal endorsements, Goldstein said.

"The CRC might have needed to have a more extensive first day of the season" that included different retailers, he said, yet the commission doesn't actually have a lot of space for error as a result of how the law is composed.

The seven clinical pot organisations, which will sell sporting maryjane at 13 dispensaries, are:

Land CCF New Jersey

Curaleaf

Columbia Care

Verano

GTI New Jersey

Rise New Jersey

TerrAscend

Those organisations are multi-state administrators, meaning they have existing pot organisations in areas across the US.

The amount Does Maryjane Cost in NJ?

The primary thing to know is that it costs a great deal, the specialists expressed, both for restorative purposes and, in the long run, for sporting purposes.

An ounce of "bloom," which is the crude bud item, costs between $320 to $480 for New Jersey restorative patients, as indicated by a new distributed report by NJ.com. There is no state-directed cost, yet there are state and neighbourhood deals charges in view of weight that add to costs set by retailers.

The expense is high contrasted with costs in different states, including Maine, Florida and those in the West Coast. That has a ton to do with supply, land expenses, and high neighbourhood and weed explicit duties, the specialists said.

Close by Pennsylvania patients likewise should follow through on extremely significant expenses for restorative cannabis, Goldstein said. He generally faults a framework overwhelmed by public partnerships and unbending administrative obstacles.

April 20 may be the informal occasion for pot smokers, yet April 21 will be the genuine day of festivity for the lawful weed industry in New Jersey.

On Thursday, grown-up use maryjane deals will become legitimate in the Nursery State — making the ways for what examiners accept could be a $2 billion market by 2025. It's been a significant delay for New Jersey's defenders of sporting weed: Citizens in the state previously endorsed a polling form measure sanctioning sporting pot deals in Nov. 2020, and Gov. Phil Murphy marked the bill into regulation in Feb. 2021.

Postpones in laying out an administrative structure for the business have left buyers standing by over a year for the second when anybody beyond 21 one years old stroll into one of the state's dispensaries and leave with legitimately bought pot.

What's more, after a significant delay, New Jersey's dispensary proprietors are anticipating that Thursday's send off should have something of "a celebratory viewpoint to it, without a doubt," Joe Bayern, Chief of weed organisation Curaleaf, tells CNBC Make It. "Individuals simply need to be important for the experience and gain and come from an instructive point of view, to see what's really going on with it."

What you can hope to see in New Jersey

Just seven organisations that got endorsement from New Jersey's Pot Administrative Bonus to start sporting deals of weed blossom and marijuana implanted items on April 21.

They get the main break at the possibly enormous market since they as of now work clinical maryjane dispensaries in the state — important they're more averse to sell out or confront other calculated difficulties on the very beginning.

Also, request is positively expected to be, all things considered, high. Only 13 all out dispensaries are set to open for sporting deals on Thursday, across a condition of in excess of 9 million individuals — in addition to clients probably flooding in from neighbouring states like Pennsylvania and New York.

Curaleaf, which is situated in Wakefield, Massachusetts, possesses and works two New Jersey areas - in Bordentown and Edgewater Park - that are adding sporting weed deals to their current clinical maryjane dispensaries on Thursday. Bayern says he's anticipating long queues toward the beginning of the day.

"We've had long queues in a portion of our areas without grown-up use. So I think this will simply be adding to that," he says. "We've welcomed additional individuals, we've chipped away at traffic studies, we've opened up new [point-of-sale] stations by any means of our dispensaries. So we've given our very best, I think, to be ready for it."

"A gram of gold is going for $62 nowadays. A gram of hash oil in Pennsylvania dispensaries sells for $100," Goldstein said. "You're letting me know pot costs more to create than the disclosure, mining and refining of a valuable metal?"

[newzzwired]

TerrAscend Hopes The USA Can Provide A Future It Controls (OTCMKTS:TRSSF)

TerrAscend Hopes The USA Can Provide A Future It Controls (OTCMKTS:TRSSF)

Olga Tsareva It might seem dramatic to state that October 17, 2018, is a date which will live in relative infamy. This day saw recreational cannabis sales begin in Canada, ushering in tens of billions of dollars in investment to spawn dozens of enterprises and thousands of jobs. But returns for investors in the space have either been abysmal or catastrophic. Large numbers of retail shareholders…

[capital10x]

TerrAscend Corp. Receives $10m Investment from Canopy Rivers

TerrAscend Corp. (CSE: TER) has received a US$10 million cash injection from Canopy Rivers as part of a US$25 million private placement. #marijuanastocks #potstocks $TER Read the full article

[don-lichterman]

TerrAscend Accelerates Michigan Retail Expansion Through Acquisition of Pinnacle

TerrAscend Accelerates Michigan Retail Expansion Through Acquisition of Pinnacle

TerrAscend Corp. TERTRSSF, a leading North American cannabis operator has entered into a definitive agreement to acquire KISA Enterprises MI, LLC and KISA Holdings, LLC (“A.k.a. Pinnacle“), a dispensary operator in Michigan, and related real estate, for $28.5 million. “The Transaction is expected to be immediately accretive to TerrAscend on both Sales and EBITDA basis,” noted TerrAscend in a…

[kofi-samata]

La juge d'American Idol, Kara DioGuardi, rejoint Cannabis Co.

La juge d’American Idol, Kara DioGuardi, rejoint Cannabis Co.

Kara Dio Guardi Rachel Deb Auteur-compositeur nominé aux Grammy Awards, producteur, directeur de disques, actrice de Broadway et ancien juge d’American Idol, Kara DioGuardi a récemment rejoint le conseil d’administration du géant américain du cannabis TerrAscend. La société cherchera à tirer parti de son “expertise en création de marque et de son sens du talent et de l’attrait des produits”…

[questlation]

Cannabis company TerrAscend moves into Michigan with $545 million all-stock Gage Growth acquisition https://questlation.com/?p=2145&feed_id=22581

[reportandinsights]

High-End Craft Cultivation is the New Demand in Cannabis Industry - Reports and Insights Study

Cannabis sativa L. (Cannabaceae) is one of the earliest medicinal plants utilized by humans. Basically, Cannabis is the preferable identification name of the plant Cannabis indica, Cannabis sativa, and of minor significance, Cannabis ruderalis. For thousands of years, the plant has served its utility for mankind for oil and fiber production, and simply as a supplement for different food items.

Cannabis is the world's most ordinarily cultivated, smuggled, and used as an unauthorized and illegal drug, and in addition to that, as the encouragement for legalization of cultivation of cannabis at home and abroad is surging, cannabis or marijuana is gaining significant attention from manufacturers, investors, and researchers across the world.

Moreover, cannabis is considered to contain a variety of medicinally essential compounds such as, terpenoids, cannabinoids, alkaloids, flavonoids, and others, which further escalates its applications in medicinal uses in the healthcare sector. Cannabis, which was once considered an unauthorized and illegal substance is believed a restricted and governed drug within several government guidelines in present times. Although the infamy is being cast off at a rapid pace, and it appears cannabis or marijuana is swiftly on its way to be accepted as mainstream.

Cannabis Market Dynamics

The fact that the world has witnessed significant steps taken and great progress made in the legalization of cannabis that resulted in the emergence and growth of a new industry. Also, being it one of the most commonly cultivated and used unlawful and prohibited drugs, the world is now getting acquainted with its various beneficial attributes, which has favorably compelled regulatory bodies to legalize the cultivation and use of cannabis across the world. Owing to this, the global cannabis market is projected to grow briskly in the near future.

The global cannabis market was valued US$ 18.1 Bn at the end of 2020 and expected to reach at a value of US$ 127.3 Bn by 2028 with a significant CAGR of 27.6%.

With the same token, cannabis or marijuana is gaining enormous momentum in the global markets, in the present times, owing to its therapeutic applications as well as medicinal benefits, which in turn is further expected to positively fuel the growth of the global cannabis market in the forthcoming years.

Cannabis is said to be helpful in losing body weight, improving lung capacity, preventing and regulating diabetes as well as seizures, treating glaucoma, fighting diseases like anxiety and depression, and more importantly, it has the potential to fight cancer. Attributing all such beneficial factors, cannabis is anticipated to gain massive traction in the years to come, therefore the global cannabis market is projected to observe major breakthroughs over the forecast period.

However, the rigid and monitoring regulatory structure for the use of cannabis/marijuana across the world is still a restraining factor for the future growth of the global cannabis market. By the same token, along with the stringent regulations, free public trade and consumption is also not allowed and legal, across various parts of the world, which is also likely to hold back the growth of the global cannabis market to the bounds over the coming years.

Nevertheless, the rapid advancements in the cannabis industry has led many major players of the market to focus on R&D and novel product development, which is further expected to accelerate the growth of the global cannabis market in the upcoming future.

Cannabis Market Segmentation

The global cannabis market is segmented on the basis of type, application, compound and region. On the basis of type, the cannabis market is segmented into Flower, Concentrates, and Others (capsules, topicals, edibles, and beverages). On the basis of application, the market is categorized into Medical and Recreational. Furthermore, the cannabis market is segmented on the basis of the compound into THC-dominant, CBD-dominant, and Balanced THC & CBD.

The research report classifies the global cannabis market based on type, application, compound and regions.

By Type

Flower

Concentrates

Others (capsules, topicals, edibles, and beverages)

By Application

Medical

Recreational

By Compound

THC-dominant

CBD-dominant

Balanced THC & CBD

By Region

North America

Latin America

Africa

Europe

Asia Pacific

Middle East

Cannabis Market Key Players

The key participating players in the global cannabis market are Canopy Growth Corporation, Aurora Cannabis Inc., MedMen, Terra Tech Corp., Aphria Inc., VIVO Cannabis Inc., The Cronos Group, Medical Marijuana Inc., STENOCARE, Tikun Olam, Organigram Holdings Inc., Cresco Labs, Indiva, Curaleaf Holding Inc., HEXO Corp., Ecofibre Limited, Harvest Health & Recreation, Green Thumb Industries, Maricann Group Inc., and TerrAscend.

A research report on the cannabis market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support the market and the factors that are acting as impedance to the growth of the market.